Platelet function analysis

被引:250
作者
Harrison, P [1 ]
机构
[1] Churchill Hosp, Oxford Haemophilia Ctr, Oxford OX3 7LJ, England
[2] Churchill Hosp, Thrombosis Unit, Oxford OX3 7LJ, England
关键词
platelets; platelet function; bleeding time; platelet aggregation; PFA-100 (R); the cone and plate(let) analyser; Ultegra-RPFA (R);
D O I
10.1016/j.blre.2004.05.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Since the last guidelines for BCSH platelet function testing were written in the late 1980s, many new tests have become available. Previously most platelet function tests were traditionally utilized to aid in the diagnosis and management of patients with platelet and haemostatic disorders. Most traditional tests were also largely restricted to the specialized laboratory or centre. However, nowadays there is also much renewed interest in monitoring the efficacy of anti-platelet therapy and measuring platelet hyper-function. A number of dedicated platelet function instruments have now become available that are much simpler to use and are beginning to be utilized as point of care instruments. These can now provide measurement of platelet function within whole blood without the requirement of sample processing. Some are also beginning to be incorporated into routine clinical use and can be utilized as not only as general screening tests of platelet function but to monitor anti-platelet therapy and to potentially assess both risk of bleeding and/or thrombosis. Modern flow cytometric-based platelet function analysis now also provides a wide variety of specific tests that can assess different aspects of platelet biology that are useful for diagnostic purposes. This review wilt highlight some of these of new tests/instruments and discuss their potential utility both within the haemostasis laboratory but also as potential point of care instruments. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:111 / 123
页数:13
相关论文
共 75 条
  • [1] Antiplatelet effect of aspirin in patients with cerebrovascular disease
    Alberts, MJ
    Bergman, DL
    Molner, E
    Jovanovic, BD
    Ushiwata, I
    Teruya, J
    [J]. STROKE, 2004, 35 (01) : 175 - 178
  • [2] Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease
    Andersen, K
    Hurlen, M
    Arnesen, H
    Seljeflot, I
    [J]. THROMBOSIS RESEARCH, 2002, 108 (01) : 37 - 42
  • [3] [Anonymous], 1988, J Clin Pathol, V41, P1322
  • [4] Billio A, 2001, HAEMATOLOGICA, V86, P220
  • [5] Budde U, 2001, Rev Clin Exp Hematol, V5, P335, DOI 10.1046/j.1468-0734.2001.00048.x
  • [6] Bugert P, 2003, THROMB HAEMOSTASIS, V90, P738
  • [7] Comparison of PFA-100 and bleeding time testing in pediatric patients with suspected hemorrhagic problems
    Cariappa, R
    Wilhite, TR
    Parvin, CA
    Luchtman-Jones, L
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (06) : 474 - 479
  • [8] Carr ME, 2003, THROMB HAEMOSTASIS, V89, P803
  • [9] Onset of force development as a marker of thrombin generation in whole blood: the thrombin generation time (TGT)
    Carr, ME
    Martin, EJ
    Kuhn, JG
    Spiess, BD
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (09) : 1977 - 1983
  • [10] Development of platelet contractile force as a research and clinical measure of platelet function
    Carr, ME
    [J]. CELL BIOCHEMISTRY AND BIOPHYSICS, 2003, 38 (01) : 55 - 78